It is an acknowledgement by the JAMA Network Open on the clinical and scientific evidence of FESPIXON®(ON101). The open access online will increase the understanding of Fespixon’s efficacy by the international diabetic foot ulcer (DFU) specialists and also raise the global profile of the new drug.
Please visit the JNO website for the full text: https://t.co/7XCUMlsjKu
Download the full text here
